Leoni Mollie 4
4 · Kura Oncology, Inc. · Filed Sep 29, 2025
Insider Transaction Report
Form 4
Leoni Mollie
Chief Medical Officer
Transactions
- Award
Common Stock
2025-09-27+82,500→ 170,753 total - Sale
Common Stock
2025-09-29$8.94/sh−12,314$110,114→ 158,439 total
Footnotes (1)
- [F1]Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023 and January 2, 2025. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on September 27, 2025, resulting in the vesting of 1/6th of the underlying shares.